下肢深静脉血栓患者肺栓塞预测模型
基于776例下肢深静脉血栓住院患者,开发并验证了肺栓塞风险预测模型及SDH评分;验证队列中模型校准良好,SDH评分AUC为0.702,特异性高于Wells和修订版Geneva评分。
要点
- SDH评分≥3分定义为PE可能,<3分为PE不太可能。
- 验证队列SDH评分AUC 0.702,敏感性67.61%,特异性61.73%。
- SDH评分特异性显著高于Wells和修订版Geneva评分。
核心结论
- 基于7项危险因素的logistic回归模型和SDH评分对下肢深静脉血栓患者肺栓塞风险评估具有良好的校准和区分度。
- 在中国人群中,SDH评分预测肺栓塞的特异性高于Wells评分和修订版Geneva评分。
研究设计与样本
- 病例对照研究,纳入2016年1月至2017年6月山西大医院血管外科776例下肢深静脉血栓患者。
- 患者随机分为开发队列543例(70%)和验证队列233例(30%)。
- 根据肺动脉CT血管造影结果分为肺栓塞组(病例组)和无肺栓塞组(对照组)。
- 在开发队列建立logistic回归模型和评分系统,在验证队列进行验证。
主要发现
- SDH评分在开发队列的敏感性76.39%、特异性55.89%、粗一致性61.33%。
- 验证队列logistic回归模型Hosmer-Lemeshow检验P>0.05,AUC 0.705(95%CI: 0.634-0.776,P<0.001)。
- 验证队列SDH评分AUC 0.702(95%CI: 0.631-0.774,P<0.001),敏感性67.61%、特异性61.73%、粗一致性63.52%。
- 验证队列Wells评分AUC 0.611(95%CI: 0.533-0.688,P=0.007),修订版Geneva评分AUC 0.585(95%CI: 0.503-0.666,P=0.040)。
- Wells评分与SDH评分AUC差异无统计学意义(0.611 vs. 0.702,P=0.059),修订版Geneva评分与SDH评分AUC差异有统计学意义(0.585 vs. 0.702,P=0.016)。
关键数值与推荐
- SDH评分项目:右下肢或双下肢1分;手术或制动1分;恶性肿瘤1分;静脉血栓栓塞史2分;D-二聚体>1,000 ng/mL 2分;无诱因2分。
- SDH评分风险分层:评分<3分为PE不太可能,评分≥3分为PE可能。
临床怎么用
- 对下肢深静脉血栓住院患者可使用SDH评分进行肺栓塞风险分层,评分≥3分提示PE可能。
- SDH评分在中国人群中特异性优于Wells评分和修订版Geneva评分,可辅助临床决策。
局限性
- 单中心研究,样本来自中国一家医院,外推性需进一步验证。
- 病例对照设计可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To develop and verify a risk predictive model/scoring system for pulmonary embolism (PE) among hospitalized patients with deep venous thrombosis of the lower extremities (LDVT). METHODS: 776 patients with LDVT were enrolled in a case-control study between January 2016 and June 2017 from the Vascular Surgery Department of Shanxi Dayi Hospital, China. They were randomly divided into development (543 patients, 70%) and validation (233 patients, 30%) databases. Based on the results of pulmonary computed tomography arteriography, patients were divided into 2 categories; those with PE were designated as the case group, whereas those without comprised the controls. A logistic regression model and scoring system for PE in patients with LDVT was established in the development database and verified in the validation database. Scoring system (Shanxi Dayi Hospital score [SDH score]) was tabulated as follows: right lower extremity or bilateral lower extremities, 1; surgery or immobilization, 1; malignant tumor, 1; history of venous thromboembolism (VTE), 2; D-dimer >1,000 ng/mL, 2; and unprovoked, 2. Calibration and discrimination of the model were assessed by the Hosmer-Lemeshow goodness of fit test and the area under the receiver operating characteristic curve (AUC). Wells score, the Revised Geneva score, and the SDH score for predictive value of PE by AUC in the validation database were compared. RESULTS: 776 patients with LDVT were divided into 2 risk categories based on the scores from the risk model as follows: PE unlikely (score <3) and PE likely (score ≥3). Sensitivity, specificity, and crude agreement of the SDH score in the development database were 76.39%, 55.89%, and 61.33%, respectively. In the validation database, the logistic regression model showed good calibration and discriminative power. The Hosmer-Lemeshow goodness of fit test P value was >0.05, and the AUC was 0.705 (95% CI: 0.634-0.776, P < 0.001). The SDH score also showed good discriminative power, and the AUC was 0.702 (95% CI: 0.631-0.774, P < 0.001). Sensitivity, specificity, and crude agreement of the SDH score in the validation database were 67.61%, 61.73%, and 63.52%, respectively. AUC for the Wells score and the Revised Geneva score was 0.611 (95% CI: 0.533-0.688, P = 0.007) and 0.585 (95% CI: 0.503-0.666, P = 0.040), respectively. Difference of the AUC was not statistically significant between the Wells score and the SDH score (0.611 vs. 0.702, P = 0.059) but was so between the Revised Geneva score and the SDH score (0.585 vs. 0.702, P = 0.016). Sensitivity of the Wells score, Revised Geneva score, and the SDH score (64.79%, 67.61% vs. 67.61%) was not statistically significant. However, the specificity of the Wells score and Revised Geneva score was significantly lower than that of the SDH score (48.77%, 39.51% vs. 61.73%). CONCLUSIONS: Our logistic regression model and the SDH score based on 7 risk factors as right lower extremity, bilateral lower extremities, unprovoked, surgery or immobilization, malignant tumor, history of VTE, and D-dimer>1,000 ng/mL showed good calibration and discriminative power for the assessment of PE risk in patients with LDVT. The SDH score is more specific for PE prediction in the Chinese population, compared with the Wells score and the Revised Geneva score.
引用
- Zhao B, Hao B, Xu H, et al. Predictive Model for Pulmonary Embolism in Patients with Deep Vein Thrombosis. Ann Vasc Surg. 2020. PMID: 31911130. doi:10.1016/j.avsg.2019.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。